XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.18%540.2M | 4.49%138.1M | 1.77%135.64M | -4.14%130.13M | -7.36%129.69M | 9.89%541.19M | -5.00%132.17M | 4.17%133.28M | 18.85%135.75M | 25.88%139.99M |
Net interest income | 1.23%568.1M | 4.29%146.37M | 1.19%143.01M | -0.20%140.05M | -1.33%137.32M | 18.76%561.18M | 1.37%140.35M | 13.98%141.32M | 28.42%140.33M | 38.05%139.18M |
-Net interest income | 11.47%851.05M | 4.20%215.38M | 7.60%215.84M | 12.60%211.16M | 22.90%207.32M | 48.63%763.51M | 32.20%206.7M | 48.15%200.59M | 62.05%187.53M | 58.79%168.68M |
-Interest income from loans and lease | ---- | ---- | 6.25%191.51M | 11.20%189.21M | 22.25%186.56M | 50.84%687.85M | 32.73%184.85M | 52.15%180.24M | 66.57%170.16M | 58.76%152.61M |
-Interest income from deposits | ---- | ---- | 18.61%5.35M | 109.50%4.39M | 198.66%3.57M | 26.71%13.43M | 81.82%5.63M | 7.61%4.51M | -16.03%2.1M | 46.27%1.2M |
-Interest income from securities | ---- | ---- | 19.87%18.99M | 14.96%17.56M | 15.46%17.18M | 32.10%62.23M | 15.97%16.23M | 24.32%15.84M | 37.90%15.28M | 60.15%14.88M |
-Total interest expense | 39.85%282.96M | 4.01%69.01M | 22.89%72.84M | 50.65%71.12M | 137.24%70M | 391.34%202.33M | 270.63%66.35M | 419.66%59.27M | 631.18%47.21M | 444.76%29.5M |
-Interest expense for deposit | 44.03%264.61M | 4.26%64.99M | 24.23%68.77M | 60.43%66.37M | 161.44%64.47M | 509.20%183.72M | 322.27%62.34M | 537.21%55.35M | 974.60%41.37M | 762.57%24.66M |
-Interest expense for long term debt and capital securities | -31.84%12.68M | -56.94%2.77M | -3.19%2.85M | -34.88%3.34M | -9.18%3.72M | 68.81%18.6M | 91.35%6.44M | 13.45%2.94M | 99.96%5.13M | 63.96%4.09M |
Non interest income | -39.53%-27.9M | -1.10%-8.27M | 8.46%-7.37M | -116.66%-9.92M | -1,042.10%-7.63M | -200.22%-19.99M | -1,318.78%-8.18M | -303.80%-8.05M | -192.64%-4.58M | -92.20%810K |
-Total premiums earned | ---- | -29.97%895K | 36.62%1.12M | 7.28%855K | 9.23%864K | 10.95%3.69M | 65.33%1.28M | 6.89%822K | 6.55%797K | -23.50%791K |
-Fees and commissions | -23.85%-49.88M | 12.58%-12.12M | -11.76%-15M | -43.64%-14.39M | -130.52%-13.01M | -662.07%-40.28M | -533.24%-13.87M | -1,829.38%-13.42M | -519.42%-10.02M | -247.23%-5.64M |
-Other non interest income | 44.78%21.99M | -51.42%3.03M | 6.06%2.89M | -26.71%3.14M | -44.09%2.69M | 87.75%15.19M | 265.57%6.23M | 29.36%2.72M | 192.28%4.28M | -7.02%4.81M |
-Gain loss on sale of assets | ---- | 96.91%-68K | 108.65%3.16M | --0 | 182.44%1.42M | --0 | ---2.2M | --1.51M | --0 | --501K |
-Dividend income | ---- | ---- | 46.98%463K | 31.78%481K | 16.33%406K | 2.84%1.41M | -0.52%381K | 5.70%315K | 6.73%365K | 0.29%349K |
Credit losses provision | 41.24%-21.51M | 62.14%-6.83M | 48.95%-4.1M | 23.98%-4.82M | -37.60%-5.76M | -6,091.00%-36.61M | -750.35%-18.05M | -1,087.87%-8.03M | -863.37%-6.34M | -202.83%-4.18M |
Non interest expense | 11.39%287.45M | 20.53%70.62M | 0.82%68.76M | 2.10%68.12M | 13.57%73.31M | 10.45%258.06M | -3.26%58.59M | 8.18%68.2M | 19.51%66.72M | 19.09%64.55M |
Occupancy and equipment | 4.27%17.23M | 0.53%4.34M | 4.14%4.37M | 6.15%4.2M | 6.53%4.33M | -6.32%16.53M | 1.53%4.31M | -6.65%4.2M | -8.24%3.95M | -11.45%4.06M |
Professional expense and contract services expense | ---- | ---- | 13.36%1.6M | -17.11%1.3M | -12.02%1.44M | -19.21%5.72M | -59.65%1.12M | -11.90%1.41M | 1.56%1.57M | 38.57%1.63M |
Selling and administrative expenses | 2.37%181.94M | 3.16%46.17M | 11.48%48.65M | 7.68%47.66M | 8.42%48.87M | 15.31%177.73M | 12.53%44.76M | 11.83%43.64M | 17.56%44.26M | 19.62%45.08M |
-General and administrative expense | 2.37%181.94M | 3.16%46.17M | 11.48%48.65M | 7.68%47.66M | 8.42%48.87M | 15.31%177.73M | 12.53%44.76M | 11.83%43.64M | 17.56%44.26M | 19.62%45.08M |
Depreciation amortization depletion | ---- | ---- | -17.16%927K | -16.90%944K | -15.50%1.05M | -14.27%4.6M | -14.70%1.11M | -14.58%1.12M | -14.46%1.14M | -13.36%1.24M |
-Depreciation and amortization | ---- | ---- | -17.16%927K | -16.90%944K | -15.50%1.05M | -14.27%4.6M | -14.70%1.11M | -14.58%1.12M | -14.46%1.14M | -13.36%1.24M |
Other non-interest expense | 65.06%88.28M | 175.56%20.12M | -25.89%13.22M | -11.27%14.02M | 40.58%17.63M | 8.22%53.48M | -41.50%7.3M | 7.35%17.84M | 43.67%15.81M | 34.49%12.54M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | |||||||||
Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | ||||||||||
Income before tax | -6.20%231.24M | 9.22%60.65M | 10.05%62.78M | -8.77%57.19M | -28.95%50.63M | -4.98%246.53M | -27.35%55.53M | -11.17%57.05M | 8.60%62.69M | 16.68%71.26M |
Income tax | -12.37%45.98M | 7.38%11.81M | -1.51%12.2M | -13.41%11.74M | -34.11%10.23M | -7.00%52.47M | -33.08%11M | -11.69%12.39M | 7.82%13.56M | 16.01%15.52M |
Earnings from equity interest net of tax | ||||||||||
Net income | -4.53%185.27M | 9.67%48.83M | 13.25%50.59M | -7.49%45.45M | -27.52%40.4M | -4.42%194.06M | -25.79%44.53M | -11.03%44.67M | 8.81%49.13M | 16.87%55.74M |
Net Income continuous operations | -4.53%185.27M | 9.67%48.83M | 13.25%50.59M | -7.49%45.45M | -27.52%40.4M | -4.42%194.06M | -25.79%44.53M | -11.03%44.67M | 8.81%49.13M | 16.87%55.74M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -4.53%185.27M | 9.67%48.83M | 13.25%50.59M | -7.49%45.45M | -27.52%40.4M | -4.42%194.06M | -25.79%44.53M | -11.03%44.67M | 8.81%49.13M | 16.87%55.74M |
Preferred stock dividends | 0.00%3.75M | 0.00%937K | 0.00%938K | 0.00%937K | 0.00%938K | -7.20%3.75M | 0.00%937K | 0.11%938K | -0.11%937K | -23.68%938K |
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -4.62%181.52M | 9.88%47.9M | 13.54%49.65M | -7.64%44.51M | -27.99%39.46M | -4.37%190.31M | -26.20%43.59M | -11.24%43.73M | 9.00%48.19M | 17.94%54.8M |
Basic earnings per share | -4.52%4.86 | 11.21%1.29 | 13.68%1.33 | -7.75%1.19 | -28.57%1.05 | -4.32%5.09 | -27.04%1.16 | -11.36%1.17 | 8.40%1.29 | 19.51%1.47 |
Diluted earnings per share | -4.73%4.83 | 10.34%1.28 | 12.82%1.32 | -7.75%1.19 | -28.08%1.05 | -4.52%5.07 | -26.58%1.16 | -11.36%1.17 | 8.40%1.29 | 18.70%1.46 |
Dividend per share | 6.00%1.06 | 12.00%0.28 | 8.00%0.27 | 4.00%0.26 | 0.00%0.25 | 11.11%1 | 4.17%0.25 | 8.70%0.25 | 13.64%0.25 | 19.05%0.25 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |